首页> 外文OA文献 >Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide

【2h】

Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide

机译：用胰高血糖素肽-1受体激动剂治疗2型糖尿病患者的治疗模式：与杜拉蛋白质相比，与杜拉替纳肽和Liraglutide相比，与杜拉替金属更高的粘附和持续性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Carlos Alatorre; Laura Fernández Landó; Maria Yu; Katelyn Brown; Leslie Montejano; Paul Juneau; Reema Mody; Ralph Swindle;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide [J] . Alatorre Carlos, Lando Laura Fernandez, Yu Maria, Diabetes, obesity & metabolism . 2017,第7期

机译：用胰高血糖素肽-1受体激动剂治疗2型糖尿病患者的治疗模式：与杜拉蛋白质相比，与杜拉替纳肽和左旋蛋白质相比，较高的粘附和持续性
2. Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study [J] . Odawara M., Miyagawa J., Iwamoto N., Diabetes, obesity & metabolism . 2016,第3期

机译：在日本2型糖尿病患者中，每周一次胰高血糖素样肽1受体激动剂dulaglutide与每日一次liraglutide相比可显着降低糖化血红蛋白：一项随机III期研究的治疗52周
3. Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials [J] . Xue X., Ren Z., Zhang A., International journal of clinical practice . 2016,第8期

机译：每周一次胰高血糖素样肽1受体激动剂与艾塞那肽和利拉鲁肽比较在2型糖尿病中的疗效和安全性：随机对照试验的系统评价
4. Adherence and Quality of Life in Patients with Type II Diabetes Mellitus [C] . Suci Nugraha, Siti Kartika Putri Social and Humaniora Research Symposium . 2018

机译：II型糖尿病患者的依从性和生活质量
5. Glucagon-like peptide-1 delivery for treatment of type 2 diabetes. [D] . Choi, Suna. 2005

机译：胰高血糖素样肽1递送用于治疗2型糖尿病。
6. Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide [O] . Carlos Alatorre, Laura Fernández Landó, Maria Yu, -1

机译：胰高血糖素样肽-1受体激动剂治疗的2型糖尿病患者的治疗方式：与每周一次艾塞那肽和利拉鲁肽相比杜拉鲁肽具有更高的依从性和持久性
7. Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9) [O] . Paolo Pozzilli, Paul Norwood, Esteban Jódar, 2017

机译：安慰剂控制的，随机试验的加入一次每周胰高血糖素的肽-1受体激动剂杜拉蛋白达克兰蛋白酶2型糖尿病患者滴定每日胰岛素狼科（奖励-9）

Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide

著录项

引文网络

相似文献

相关主题

期刊订阅